Tilray Brands' (TLRY.TO) Tilray Medical unit said Thursday it launched its first medical cannabis product in Panama.
The launch follows the shipment of Tilray Oral Solution CBD100 from the company's EU-GMP-certified production facility in Portugal through its joint venture with Solana Life Group. The product will be distributed through Farmacias Arrocha, one of Panama's pharmacy chains, and will be available to patients by prescription, the company said.
The solution is "intended for use, where authorized, in patients with qualifying medical conditions authorized under Panamanian legislation," the company added.